US Bancorp’s TherapeuticsMD TXMD Stock Holding History

US Bancorp’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$497	Hold	246	–	–	﹤0.01%	4003
2025 Q4	$401	Hold	246	–	–	﹤0.01%	3937
2025 Q3	$264	Hold	246	–	–	﹤0.01%	3920
2025 Q2	$285	Hold	246	–	–	﹤0.01%	4045
2025 Q1	$228	Hold	246	–	–	﹤0.01%	4088
2024 Q4	$212	Hold	246	–	–	﹤0.01%	4080
2024 Q3	$408	Hold	246	–	–	﹤0.01%	3968
2024 Q2	$396	Sell	246 -164	-40%	-$331	﹤0.01%	3877
2024 Q1	$939	Buy	410 +164	+67%	+$380	﹤0.01%	3819
2023 Q4	$554	Hold	246	–	–	﹤0.01%	3837
2023 Q3	$743	Hold	246	–	–	﹤0.01%	3813
2023 Q2	$1.01K	Hold	246	–	–	﹤0.01%	3806
2023 Q1	$923	Hold	246	–	–	﹤0.01%	3888
2022 Q4	$1.38K	Hold	246	–	–	﹤0.01%	3865
2022 Q3	$2K	Hold	246	–	–	﹤0.01%	3870
2022 Q2	$2K	Hold	246	–	–	﹤0.01%	3887
2022 Q1	$5K	Hold	246	–	–	﹤0.01%	3630
2021 Q4	$4K	Sell	246 -160	-39%	-$4.79K	﹤0.01%	3740
2021 Q3	$15K	Sell	406 -4	-1%	-$178	﹤0.01%	3280
2021 Q2	$25K	Buy	410 +4	+1%	+$242	﹤0.01%	3015
2021 Q1	$27K	Hold	406	–	–	﹤0.01%	2892
2020 Q4	$25K	Hold	406	–	–	﹤0.01%	2824
2020 Q3	$32K	Hold	406	–	–	﹤0.01%	2597
2020 Q2	$25K	Sell	406 -1,716	-81%	-$99.9K	﹤0.01%	2727
2020 Q1	$112K	Sell	2,122 -60	-3%	-$5.95K	﹤0.01%	1967
2019 Q4	$264K	Hold	2,182	–	–	﹤0.01%	1688
2019 Q3	$396K	Hold	2,182	–	–	﹤0.01%	1483
2019 Q2	$284K	Hold	2,182	–	–	﹤0.01%	1670
2019 Q1	$531K	Hold	2,182	–	–	﹤0.01%	1362
2018 Q4	$416K	Buy	2,182 +486	+29%	+$119K	﹤0.01%	1425
2018 Q3	$556K	Sell	1,696 -80	-5%	-$24.5K	﹤0.01%	1399
2018 Q2	$554K	Buy	1,776 +80	+5%	+$24.4K	﹤0.01%	1390
2018 Q1	$413K	Hold	1,696	–	–	﹤0.01%	1530
2017 Q4	$512K	Hold	1,696	–	–	﹤0.01%	1423
2017 Q3	$449K	Buy	1,696 +1,436	+552%	+$415K	﹤0.01%	1466
2017 Q2	$69K	Sell	260 -1,560	-86%	-$391K	﹤0.01%	2384
2017 Q1	$655K	Buy	1,820 +1,636	+889%	+$506K	﹤0.01%	1273
2016 Q4	$53K	Hold	184	–	–	﹤0.01%	2410
2016 Q3	$63K	Hold	184	–	–	﹤0.01%	2325
2016 Q2	$78K	Hold	184	–	–	﹤0.01%	2191
2016 Q1	$59K	Hold	184	–	–	﹤0.01%	2300
2015 Q4	$95K	Hold	184	–	–	﹤0.01%	2096
2015 Q3	$54K	Buy	184 +124	+207%	+$44.1K	﹤0.01%	2419
2015 Q2	$24K	Hold	60	–	–	﹤0.01%	2865
2015 Q1	$18K	Hold	60	–	–	﹤0.01%	2979
2014 Q4	$13K	Hold	60	–	–	﹤0.01%	3038
2014 Q3	$14K	Hold	60	–	–	﹤0.01%	2958
2014 Q2	$13K	Hold	60	–	–	﹤0.01%	3006
2014 Q1	$19K	Buy	+60	New	+$19.1K	﹤0.01%	2861

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

US Bancorp's TXMD Position: Q1 2026 in Review

US Bancorp held its TherapeuticsMD (TXMD) position steady in Q1 2026 at 246 shares worth $497. The position accounts for ﹤0.01% of the portfolio, ranked #4003.

US Bancorp first reported a position in TXMD in Q1 2014 and has held it in 49 quarters since. The position peaked at $655K in Q1 2017. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

US Bancorp held 246 shares of TherapeuticsMD worth $497 as of Q1 2026.
US Bancorp left its TherapeuticsMD share count unchanged in Q1 2026.
TherapeuticsMD made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #4003 holding.
US Bancorp first reported a position in TherapeuticsMD in Q1 2014 and has held it in 49 quarters since.
US Bancorp's TherapeuticsMD position peaked at $655K in Q1 2017.
49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.